MOODMIND: A Pilot Feasibility Study of Artificial Intelligence for Major Depressive Disorder Screening in Tuberculosis Patients

MOODMIND:人工智能在结核病患者重度抑郁症筛查中的应用可行性试点研究

阅读:1

Abstract

BACKGROUND: Major Depressive Disorder (MDD) can occur in patients with tuberculosis. The purpose of this research was to develop an early detection system for MDD and conduct an accuracy test. METHODS: The MOODMIND application uses Natural Language Processing (NLP) with sentiment analysis techniques. MOODMIND offers both speech and text options and is available in Indonesian/English. The screening results were compared with physician clinical interview. Single blinding was used so that doctor was unaware of the application test. RESULTS: The app asks open- and closed-ended questions for MDD identification based on the DSM-5. The test results were divided into non-depressive (none or at-risk) and suspected depression groups. Among the 21 subjects, MOODMIND showed 67% (95% CI: 9.4-99.2%) sensitivity and 100% (95% CI: 81.5-100%) specificity. CONCLUSIONS: MOODMIND demonstrated accuracy results in pilot study but required advanced research with more sample and diverse settings. Ease is advantageous because the steps are simple, but it can be improved by adding words related to depression in the lexicon adjustment for increasing diagnostic performance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。